An invertebrate infection model for evaluating anti-fungal agents against dermatophytosis.

Abstract

Animal models of pathogenic infection are needed to evaluate candidate compounds for the development of anti-infectious drugs. Dermatophytes are pathogenic fungi that cause several infectious diseases. We established a silkworm dermatophyte infection model to evaluate anti-fungal drugs. Injection of conidia of the dermatophyte Arthroderma vanbreuseghemii into silkworms was lethal. A. vanbreuseghemii conidia germinated in liquid culture were more potent against silkworms than non-germinated conidia. Germinated conidia of other dermatophytes, Arthroderma benhamiae, Trichophyton rubrum, and Microsporum canis, also killed silkworms. Injection of heat-treated germinated A. vanbreuseghemii conidia did not kill silkworms, suggesting that only viable fungi are virulent. Injecting terbinafine or itraconazole, oral drugs used clinically to treat dermatophytosis, into the silkworm midgut had therapeutic effects against infection with germinated A. vanbreuseghemii conidia. When silkworms were injected with A. vanbreuseghemii expressing enhanced green fluorescent protein (eGFP), mycelial growth of the fungus was observed in the fat body and midgut. Injection of terbinafine into the silkworm midgut, which corresponds to oral administration in humans, inhibited the growth of A. vanbreuseghemii expressing eGFP in the fat body. These findings suggest that the silkworm infection model with eGFP-expressing dermatophytes is useful for evaluating the therapeutic activity of orally administered anti-fungal agents against dermatophytes.

• Authors: Masaki Ishii, Yasuhiko Matsumoto, Tsuyoshi Yamada, Shigeru Abe, Kazuhisa Sekimizu
• Journal: Scientific reports (Sci Rep) Vol. 7 Issue 1 Pg. 12289 (09 25 2017) ISSN: 2045-2322 [Electronic] England
• PMID: 28947778 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antifungal Agents
• enhanced green fluorescent protein
• Green Fluorescent Proteins

Topics

• Animals
• Antifungal Agents (therapeutic use)
• Arthrodermataceae (drug effects, genetics, pathogenicity)
• Bombyx (microbiology)
• Disease Models, Animal
• Drug Evaluation, Preclinical (methods)
• Genes, Reporter (genetics)
• Green Fluorescent Proteins (genetics)
• Humans
• Spores, Fungal (pathogenicity)
• Tinea (drug therapy, microbiology)
• Treatment Outcome